查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722463

2025-2033年生物技术市场报告（依产品类型、技术、应用和地区）

Biotechnology Market Report by Product Type, Technology, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2024年全球生技市场规模达7,615亿美元。展望未来， IMARC Group预计到2033年市场规模将达到13,159亿美元，2025-2033年期间的成长率（CAGR）为6.27%。个人化医疗研发 (R&D) 的不断增加、基因工程的众多进步以及对永续农业的需求不断增长是推动市场发展的一些主要因素。

生物技术是一个多学科领域，涵盖利用生物体、细胞和生物系统来开发创新产品和技术。它涉及利用分子和细胞层面的生物过程和生物体来应对医疗保健、农业和环境管理等行业的各种挑战。生物技术包括基因工程、生物製药、生物资讯学和合成生物学等领域，旨在创造新的解决方案、改善现有流程并增进我们对生命系统的理解。该领域在塑造现代医学、永续农业以及多种应用的新材料的开发中发挥着至关重要的作用。

由于基因研究和分子生物学理解的快速进步，基因编辑、个人化医疗和新疗法等领域的创新不断涌现，将在预测期内刺激市场成长。此外，慢性病盛行率的上升和针对性治疗的需求增加了对生物製药和精准医疗的需求，从而对市场成长产生了积极影响。此外，由于全球人口不断增长和可耕地面积有限，对永续农业解决方案的需求不断增加，加速了生物技术在作物改良和生物农药中的应用。除此之外，生物技术与资讯技术的融合（即生物资讯学）增强了数据驱动的研究和开发洞察力，正在推动市场成长。此外，由于对环境永续性的关注度不断提高，生物修復方法和生物燃料的发展也促进了市场的成长。

生物技术市场趋势/驱动因素：

基因工程的快速进步

基因工程的显着进步，以革命性的 CRISPR-Cas9 技术为突出代表，代表了生物技术市场的主要驱动力。这项技术使科学家能够精确地修改生物体内的基因，为医学、农业和工业过程的应用带来了前所未有的潜力。在医疗保健领域，基因工程促进了针对遗传疾病和癌症的创新基因疗法的开发，为个人化治疗提供了一个有希望的途径。此外，透过改造微生物来生产胰岛素和酵素等有价值化合物的能力已经改变了製药和工业製造。

个人化医疗和治疗的需求不断增加

根据个人基因组成定制的个人化医疗概念在生物技术市场越来越受到关注。基因组定序技术的进步使得分析个人遗传密码和识别与疾病相关的遗传变异成为可能。这导致了针对患者独特遗传特征的标靶疗法的发展，提高了治疗效果并减少了不良反应。生物技术使得单株抗体和基因疗法等生物製药的生产成为可能，符合个人化医疗的原则。此外，基于基因标记的诊断可以实现早期疾病检测和预测，从而重塑医疗保健实践，使其更加精确和个人化。

对永续农业解决方案的需求日益增长

全球对粮食的需求不断增长，加上对环境问题的担忧和对永续农业实践的需求，推动了农业领域采用生物技术解决方案。为提高产量、抗虫害能力和营养成分而进行的基因改造作物（GMO）是生物技术对农业影响的例子。源自天然生物的生物农药由于对环境的影响较小，比传统化学农药更受青睐。生物技术提供了优化植物特性、提高作物对气候变迁的适应能力和增加养分效率的工具，有助于粮食安全和资源永续性。这一驱动因素反映了生物技术在解决农业领域紧迫挑战同时最大限度地减少生态足迹方面发挥的关键作用。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球生物技术市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 仪器
  • 试剂
  • 软体和服务

第七章：市场区隔：依技术

  • 奈米生物技术
  • 组织工程与再生
  • DNA定序
  • 基于细胞的检测
  • 发酵
  • PCR技术
  • 色谱法
  • 其他的

第 8 章：市场区隔：按应用

  • 卫生保健
  • 食品和农业
  • 自然资源与环境
  • 工业加工
  • 生物资讯学
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Amgen Inc.
    • Biocon Limited
    • Biogen Inc.
    • F. Hoffmann-La Roche AG
    • Genmab A/S
    • Lonza Group AG
    • Novartis AG
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Regeneron Pharmaceuticals Inc.
    • Seagen Inc.
    • Syngenta AG
    • Vertex Pharmaceuticals Incorporated
Product Code: SR112025A5785

The global biotechnology market size reached USD 761.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1,315.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.27% during 2025-2033. The increasing research and development (R&D) in personalized medicine, numerous advancements in genetic engineering, and escalating demand for sustainable agriculture are some of the major factors propelling the market.

Biotechnology is a multidisciplinary field that encompasses the use of living organisms, cells, and biological systems to develop innovative products and technologies. It involves harnessing biological processes and organisms at the molecular and cellular level to address various challenges across industries, such as healthcare, agriculture, and environmental management. Biotechnology includes areas like genetic engineering, biopharmaceuticals, bioinformatics, and synthetic biology, all aimed at creating new solutions, improving existing processes, and advancing our understanding of living systems. This field plays a crucial role in shaping modern medicine, sustainable agriculture, and the development of novel materials for diverse applications.

The rising innovation in areas, including gene editing, personalized medicine, and novel therapies, due to rapid advancements in genetic research and the understanding of molecular biology, will stimulate the market growth during the forecast period. Moreover, the increasing prevalence of chronic diseases and the need for targeted treatments have augmented the demand for biopharmaceuticals and precision medicine, thus positively influencing the market growth. Additionally, the heightening demand for sustainable agricultural solutions owing to the expanding global population and limited arable land has accelerated the adoption of biotechnological techniques in crop improvement and biopesticides. Apart from this, the convergence of biotechnology with information technology, known as bioinformatics, that enhances data-driven insights for research and development is propelling the market growth. Furthermore, the development of bioremediation methods and biofuels on account of the escalating focus on environmental sustainability is contributing to market growth.

Biotechnology Market Trends/Drivers:

Rapid advancements in genetic engineering

The remarkable progress in genetic engineering, prominently exemplified by the revolutionary CRISPR-Cas9 technology, represents a primary driver in the biotechnology market. This technique allows scientists to precisely modify genes within organisms, presenting unprecedented potential for applications in medicine, agriculture, and industrial processes. In healthcare, genetic engineering facilitates the development of innovative gene therapies for genetic disorders and cancers, offering promising avenues for personalized treatments. Moreover, the ability to engineer microbes for the production of valuable compounds like insulin and enzymes has transformed pharmaceutical and industrial manufacturing.

Increasing demand for personalized medicine and therapeutics

The concept of personalized medicine, tailored to an individual's genetic makeup, is gaining traction in the biotechnology market. Advancements in genomic sequencing technologies have made it possible to analyze an individual's genetic code and identify genetic variations linked to diseases. This has led to the development of targeted therapies that address the unique genetic characteristics of patients, enhancing treatment efficacy and reducing adverse effects. Biotechnology enables the production of biopharmaceuticals such as monoclonal antibodies and gene therapies, aligning with the principles of personalized medicine. Additionally, diagnostics based on genetic markers allow for early disease detection and prognosis, reshaping healthcare practices toward more precise and individualized approaches.

Rising need for sustainable agriculture solutions

The increasing global demand for food, coupled with environmental concerns and the need for sustainable agricultural practices, fuels the adoption of biotechnological solutions in farming. Genetically modified crops (GMOs) engineered for enhanced yield, pest resistance, and nutritional content are examples of biotechnology's influence on agriculture. Biopesticides derived from naturally occurring organisms are gaining preference over traditional chemical pesticides owing to their reduced environmental impact. Biotechnology offers tools to optimize plant traits, improve crop resilience to climate change, and increase nutrient efficiency, contributing to food security and resource sustainability. This driver reflects the critical role of biotechnology in addressing pressing challenges within the agriculture sector while minimizing ecological footprints.

Biotechnology Industry Segmentation:

Breakup by Product Type:

  • Instruments
  • Reagents
  • Software and Services

Instruments form the foundation of advanced research and diagnostics, enabling precise analysis and experimentation. Reagents are essential components that fuel experimental processes, facilitating accurate results and breakthroughs. Software plays a pivotal role, providing data analysis, visualization, and integration solutions, enhancing efficiency and accuracy in biotechnological endeavors. Services encompass consulting, training, and technical support, nurturing collaboration and aiding in the effective utilization of tools.

Furthermore, these components synergistically push the boundaries of biotechnology, fostering innovation and driving advancements that impact diverse sectors such as healthcare, agriculture, and environmental sciences. As the industry evolves, the strategic interplay of instruments, reagents, software, and services continues to shape the trajectory of biotechnology, fueling growth, discovery, and progress.

Breakup by Technology:

  • Nanobiotechnology
  • Tissue Engineering and Regeneration
  • DNA Sequencing
  • Cell-Based Assays
  • Fermentation
  • PCR Technology
  • Chromatography
  • Others

Nanobiotechnology integrates nanoscale materials with biological systems, revolutionizing drug delivery, diagnostics, and therapies. Tissue engineering and regeneration pioneers novel approaches for creating functional tissues, addressing organ shortages and medical needs. DNA sequencing enables comprehensive genomic analysis, guiding personalized medicine and disease understanding. Cell-based assays provide insights into cellular behavior, supporting drug development and toxicity testing. Fermentation is a cornerstone for bioprocessing, producing biofuels, pharmaceuticals, and enzymes. PCR Technology amplifies DNA, underpinning diagnostics and genetic research.

Chromatography separates biomolecules with precision, crucial in drug purification and analytical processes. These intertwined advancements drive the market's progress, fostering innovation and solutions across healthcare, agriculture, and environmental sectors.

Breakup by Application:

  • Healthcare
  • Food and Agriculture
  • Natural Resources and Environment
  • Industrial Processing
  • Bioinformatics
  • Others

Healthcare dominates the market

Healthcare serves as a pivotal driving force behind the biotechnology market, catalyzing innovations that transform patient care and medical practices. Biotechnology solutions play a vital role in diagnostics, treatment development, and personalized medicine. From advanced DNA sequencing enabling precise disease identification to biopharmaceuticals revolutionizing treatment modalities, the synergy between healthcare and biotechnology yields breakthrough therapies, improved patient outcomes, and enhanced disease management.

As healthcare and biotechnology intertwine, novel discoveries in areas such as gene editing, synthetic biology, and biomarker development further propelling the market growth. The biotechnology sector's continual evolution addresses current medical challenges and paves the way for future advancements, shaping the landscape of healthcare delivery and underscoring its significance as a critical driver of progress within the biotechnology domain.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region boasts a robust ecosystem of research, innovation, and industry collaboration. The region's strong investment in research and development (R&D), coupled with its well-established regulatory frameworks, fosters an environment conducive to biotechnological breakthroughs. Various leading universities, research institutions, and biotech companies converge to push the boundaries of scientific discovery and technological advancements.

Furthermore, the rising emphasis of the North America region on entrepreneurship and venture capital further accelerates the commercialization of novel biotech solutions. With a history of pioneering achievements in areas such as genomics, pharmaceuticals, and medical devices, North America's influential role continues to shape the global biotechnology landscape, catalyzing growth, fostering innovation, and driving positive societal and economic impacts.

Competitive Landscape:

Key players in the biotechnology market have introduced groundbreaking innovations. Leading biopharmaceutical companies are developing mRNA-based vaccines that demonstrated remarkable efficacy in pandemic response. Additionally, advancements in CRISPR-based gene editing techniques have enabled precise and efficient modifications in various organisms, promising transformative applications in genetic therapies and modified crops. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in drug discovery and development processes is accelerating the identification of potential drug candidates. These innovations reflect the industry's commitment to addressing global challenges, ranging from disease outbreaks to food security, through cutting-edge biotechnological solutions with the potential to reshape medical treatments, agriculture practices, and industrial processes. We also expect the market to witness new entrants, consolidation of portfolios, and an increase in strategic partnerships and collaborations among vendors to drive healthy competition within the domain during the forecast period.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Amgen Inc.
  • Biocon Limited
  • Biogen Inc.
  • F. Hoffmann-La Roche AG
  • Genmab A/S
  • Lonza Group AG
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Seagen Inc.
  • Syngenta AG
  • Vertex Pharmaceuticals Incorporated

Recent Developments:

In May 2022, F. Hoffmann-La Roche Ltd, a leading healthcare enterprise headquartered in Switzerland, introduced the innovative breast cancer antibody cocktail drug, PHESGO, to the Indian market. This breakthrough offering comes with a compelling advantage, as it is not only priced at a remarkable 20% lower than existing therapies but also offers a more streamlined and convenient administration process. It specifically targets HER-2 positive breast cancer, a challenging and prevalent subtype, while holding the distinction of being sanctioned for both early and advanced stages, including metastatic cases.

In January 2021, Novartis AG, a renowned pharmaceutical leader, entered into a strategic collaboration with Alnylam, a pioneering biotechnology company specializing in RNA interference (RNAi) technology. This innovative partnership aims to harness Alnylam's cutting-edge small interfering RNA (siRNA) technology to pave the way for a revolutionary targeted therapy. The focus of this collaboration centers on restoring optimal liver function, a critical aspect in numerous medical conditions.

In Jan 2023, Pfizer Inc., a global leader in biopharmaceuticals, collaborated with Gero, an avant-garde biotechnology company renowned for its advanced technology platform. This strategic research collaboration marks a convergence of expertise and technology, aiming to unlock new insights into the complex realm of fibrotic diseases. By harnessing Pfizer's extensive domain knowledge and Gero's state-of-the-art machine-learning capabilities, the partnership endeavors to chart unexplored territories in the understanding of genes and pathways linked to fibrosis - a group of disorders characterized by tissue scarring and dysfunction.

Key Questions Answered in This Report

  • 1.How big is the biotechnology market?
  • 2.What is the expected growth rate of the global biotechnology market during 2025-2033?
  • 3.What are the key factors driving the global biotechnology market?
  • 4.What has been the impact of COVID-19 on the global biotechnology market?
  • 5.What is the breakup of the global biotechnology market based on the application?
  • 6.What are the key regions in the global biotechnology market?
  • 7.Who are the key players/companies in the global biotechnology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biotechnology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Nanobiotechnology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tissue Engineering and Regeneration
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cell-Based Assays
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Fermentation
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 PCR Technology
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Chromatography
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Food and Agriculture
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Natural Resources and Environment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Industrial Processing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Bioinformatics
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amgen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Biocon Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biogen Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Genmab A/S
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Lonza Group AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Novo Nordisk A/S
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Regeneron Pharmaceuticals Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Seagen Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Syngenta AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 SWOT Analysis
    • 14.3.13 Vertex Pharmaceuticals Incorporated
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biotechnology Market: Major Drivers and Challenges
  • Figure 2: Global: Biotechnology Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Biotechnology Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Biotechnology Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Biotechnology Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Biotechnology Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Biotechnology Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Biotechnology (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Biotechnology (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Biotechnology (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Biotechnology (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Biotechnology (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Biotechnology (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Biotechnology (Nanobiotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Biotechnology (Nanobiotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Biotechnology (Tissue Engineering and Regeneration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Biotechnology (Tissue Engineering and Regeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Biotechnology (DNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Biotechnology (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Biotechnology (Cell-Based Assays) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Biotechnology (Cell-Based Assays) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Biotechnology (Fermentation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Biotechnology (Fermentation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Biotechnology (PCR Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Biotechnology (PCR Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Biotechnology (Chromatography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Biotechnology (Chromatography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Biotechnology (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Biotechnology (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Biotechnology (Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Biotechnology (Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Biotechnology (Food and Agriculture) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Biotechnology (Food and Agriculture) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Biotechnology (Natural Resources and Environment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Biotechnology (Natural Resources and Environment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Biotechnology (Industrial Processing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Biotechnology (Industrial Processing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Biotechnology (Bioinformatics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Biotechnology (Bioinformatics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Biotechnology (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Biotechnology (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: North America: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: North America: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: United States: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: United States: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Canada: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Canada: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Asia-Pacific: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Asia-Pacific: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: China: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: China: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Japan: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Japan: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: India: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: India: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: South Korea: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: South Korea: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Australia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Australia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Indonesia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Indonesia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Europe: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Europe: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Germany: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Germany: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: France: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: France: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: United Kingdom: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: United Kingdom: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Italy: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Italy: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Spain: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Spain: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Russia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Russia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Latin America: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Latin America: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Brazil: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Brazil: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Mexico: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Mexico: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Middle East and Africa: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Middle East and Africa: Biotechnology Market: Breakup by Country (in %), 2024
  • Figure 90: Middle East and Africa: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Global: Biotechnology Industry: SWOT Analysis
  • Figure 92: Global: Biotechnology Industry: Value Chain Analysis
  • Figure 93: Global: Biotechnology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biotechnology Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Biotechnology Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Biotechnology Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Biotechnology Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Biotechnology Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Biotechnology Market: Competitive Structure
  • Table 7: Global: Biotechnology Market: Key Players